Physician
Manhattan Beach Obgyn, P.C.
Manhattan Beach Obgyn, P.C. was paid $8.01M by Medicaid between Jan 2018 and Dec 2024, across 87 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 18% of everything it billed.
33Billing provider infoMANHATTAN BEACH OBGYN, P.C.
BROOKLYN, NY 11235
BROOKLYN, NY 11235
33aNPI1598924458assigned 06/05/2008
33bProvider typeObstetrics & Gynecology Physician
28Total paid$8.01M
24GClaims222,076
24DCodes billed87
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in New York
Rank by total paid#10 of 762
Median peer was paid$22K
This provider vs. median370×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,539 | $86K | |
| 2019 | 2,273 | $125K | |
| 2020 | 11,334 | $540K | |
| 2021 | 65,131 | $2.48M | |
| 2022 | 94,792 | $3.32M | |
| 2023 | 27,613 | $912K | |
| 2024incomplete | 19,394 | $550K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 19,658 | 16,757 | $1.46M |
| 76830 | Ultrasound, transvaginal | 15% | 12,049 | 11,859 | $1.22M |
| 81514 | 7.2% | 2,636 | 2,631 | $576K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.5% | 11,255 | 10,372 | $523K |
| 93976 | 6.4% | 3,994 | 3,982 | $512K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 5.4% | 4,970 | 4,934 | $433K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.1% | 9,303 | 9,229 | $249K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.1% | 9,302 | 9,228 | $249K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.6% | 2,415 | 2,414 | $205K |
| 59840 | 2.1% | 910 | 910 | $172K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2.1% | 2,291 | 1,924 | $167K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.0% | 1,662 | 1,658 | $161K |
75 more codes
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.7% | 5,180 | $139K |
| 84410 | 1.7% | 3,466 | $138K | |
| 81025 | 1.1% | 16,335 | $90K | |
| 58558 | 1.1% | 74 | $88K | |
| 99385 | <1% | 879 | $76K | |
| 82157 | <1% | 3,352 | $76K | |
| 82670 | <1% | 3,399 | $74K | |
| 84403 | <1% | 3,464 | $69K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 693 | $68K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 3,264 | $61K |
| 82627 | <1% | 3,466 | $60K | |
| 84144 | <1% | 3,558 | $58K | |
| 84146 | <1% | 3,474 | $52K | |
| 83001 | <1% | 3,484 | $50K | |
| 83002 | <1% | 3,482 | $50K | |
| 86696 | <1% | 3,333 | $50K | |
| 84270 | <1% | 3,470 | $49K | |
| 57454 | <1% | 298 | $43K | |
| 84481 | <1% | 3,446 | $42K | |
| 86800 | <1% | 3,452 | $42K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,443 | $41K |
| 99442 | <1% | 593 | $40K | |
| 82785 | <1% | 3,162 | $40K | |
| 86376 | <1% | 3,450 | $39K | |
| 86780 | <1% | 3,602 | $37K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 542 | $37K |
| 84702 | <1% | 3,195 | $37K | |
| 86769 | <1% | 787 | $33K | |
| 86695 | <1% | 3,346 | $32K | |
| 86803 | <1% | 3,130 | $31K | |
| 86704 | <1% | 3,551 | $30K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 209 | $29K |
| 86705 | <1% | 3,379 | $28K | |
| 86706 | <1% | 3,544 | $27K | |
| 99441 | <1% | 679 | $26K | |
| 87340 | <1% | 3,318 | $24K | |
| 84439 | <1% | 3,436 | $24K | |
| 81002 | <1% | 13,735 | $21K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 929 | $14K |
| 82607 | <1% | 1,181 | $14K | |
| 82668 | <1% | 942 | $14K | |
| 82728 | <1% | 1,184 | $13K | |
| 82746 | <1% | 1,184 | $12K | |
| 80074 | <1% | 250 | $9K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 68 | $6K |
| 84432 | <1% | 481 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 426 | $5K |
| 86708 | <1% | 439 | $4K | |
| 99386 | <1% | 43 | $4K | |
| 84703 | <1% | 631 | $3K | |
| S0190 | Mifepristone, oral, 200 mg | <1% | 12 | $3K |
| 58120 | <1% | 12 | $3K | |
| 99401 | <1% | 85 | $3K | |
| 86304 | <1% | 160 | $3K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 16 | $2K |
| 82166 | <1% | 67 | $2K | |
| 58300 | <1% | 13 | $1K | |
| 82378 | <1% | 96 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,592 | $1K |
| 82105 | <1% | 113 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 68 | $772.67 |
| 83520 | <1% | 40 | $495.69 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 21 | $477.98 |
| 86777 | <1% | 29 | $340.92 | |
| 86765 | <1% | 26 | $283.69 | |
| 86778 | <1% | 17 | $217.77 | |
| 86709 | <1% | 286 | $200.20 | |
| 86762 | <1% | 14 | $179.06 | |
| 86644 | <1% | 14 | $179.06 | |
| 84402 | <1% | 1,921 | $88.30 | |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 12 | $57.60 |
| 87481 | <1% | 20 | $31.19 | |
| 99072 | <1% | 434 | $0.01 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 108 | $0.00 |
| 99000 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRONFMAN, DMITRIY (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| PBGS, LLC | Brooklyn, NY | $11.65M |
| Best Women's Medical Care, PC | Brooklyn, NY | $2.55M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.